Answers are grounded in this paper and cite their sources.
We studied 26 patients in a randomized, placebo-controlled, double-blind parallel trial to evaluate the efficacy and safety of donepezil in chronic poststroke aphasia. Donepezil (10 mg/day) improved aphasia severity at endpoint (week 16) relative to placebo (p = 0.037).
No takes yet. Share an insight, caveat, or question.
Berthier et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: